SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
RNAi
An SI Board Since May 2003
Posts SubjectMarks Bans
671 52 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
271<i>From The Scientist: biomedcentral.com; August 16, 2004 Second RNAi patnsaf-8/16/2004
270>>Ambion Licenses ddRNAi as Part of Infringement Settlement with Benitec tuck-8/11/2004
269Off topic: targeting tumors with nanotechnology. Sounds pretty interesting (thaThomas-8/11/2004
268Acuity announces first IND for Wet AMD, ahead of Sirna and the rest of the gang Thomas-8/10/2004
267from isis report today. mgt said they will broadly participate with alnylam and bob zagorin-8/5/2004
266Hybridon Licenses Key VEGF Patents to Alnylam for Treatment of Ocular Diseases wkeokalani'nui-8/3/2004
265Another article from Eureka. This one about the mechanics of RNAi cleaving actiThomas-8/2/2004
264Sirna Therapeutics & Archemix Form Exclusive Aptamer Manufacturing Alliance nigel bates-7/28/2004
263was lucky enough to sell gnta before the debacle and even though i've tradedbob zagorin-7/27/2004
262Referenced article makes me wonder if we'll see any substantial RNA silencinIan@SI-7/27/2004
261Drug Discovery & Development looks at RNAi, with emphasis on therapeutic isstuck-7/27/2004
260[Sustained small interfering RNA-mediated human immunodeficiency virus type 1 intuck-7/20/2004
259Compugen Announces Discovery of Abundant RNA Editing Sites in the Human Transcrinigel bates-7/19/2004
258>>NEW YORK, July 16 (GenomeWeb News) - A consortium of European researchertuck-7/16/2004
257>>LOS ANGELES, July 15 /PRNewswire-FirstCall/ -- In a groundbreaking discotuck-7/15/2004
256well i was fortunate enough to have a fair amount of the old RZYM which ran intobob zagorin-7/14/2004
255I just began looking at this stock, and was wondering if anyone knew why it was manittou-7/13/2004
254CYTR has weakened considerably of late. There have been ethical issues around ttuck-7/13/2004
253Thanks, Tuck. Appreciate the Atugen piece and the thoughts on Apharmas PR. CheerThomas-7/12/2004
252Since you folow RNAI, the company . . . >>Atugen Strikes Contract Resetuck-7/10/2004
251More the latter, as the only thing they're talking about in detail is in vittuck-7/10/2004
250Thomas...I must confess to being a nurse with a personal interest in cancer and zeta1961-7/9/2004
249Is this progress on the delivery question or just a good sounding press release?Thomas-7/9/2004
248Hi Zeta, Thanks for that abstract. That sounds pretty interesting. Can you expThomas-7/9/2004
247Promising sounding approach to use siRNA in combination with chemo and radiationThomas-7/9/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News